Please use this identifier to cite or link to this item:
|Title:||Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure||Authors:||Aung, T.
|Issue Date:||Jan-2004||Citation:||Aung, T., Oen, F.T.S., Wong, H.-T., Chan, Y.-H., Khoo, B.-K., Liu, Y.-P., Ho, C.-L., See, J., Thean, L.H., Viswanathan, A.C., Seah, S.K.L., Chew, P.T.K. (2004-01). Randomised controlled trial comparing the effect of brimonidine and timolol on visual field loss after acute primary angle closure. British Journal of Ophthalmology 88 (1) : 88-94. ScholarBank@NUS Repository. https://doi.org/10.1136/bjo.88.1.88||Abstract:||Aim: To compare the effect of brimonidine and timolol in reducing visual field loss in patients with acute primary angle closure (APAC). Methods: In addition to standard acute medical treatment, patients presenting with APAC were randomised to either brimonidine 0.2% or timolol 0.5% upon diagnosis, then twice daily for 4 weeks. After laser peripheral iridotomy (LPI), subjects underwent three baseline perimetry tests during the first week, and then at weeks 4, 8, 12, and 16. Pointwise linear regression analysis was applied to the field series of each of these subjects starting with the third test (total of five tests per subject). Progression was defined as a significant regression slope (p||Source Title:||British Journal of Ophthalmology||URI:||http://scholarbank.nus.edu.sg/handle/10635/130035||ISSN:||00071161||DOI:||10.1136/bjo.88.1.88|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jun 17, 2021
WEB OF SCIENCETM
checked on Jun 9, 2021
checked on Jun 18, 2021
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.